MIRASOL's ELAHERE
![ASCO 2023: MIRASOL's ELAHERE demonstrates transformative potential in treating platinum-resistant ovarian cancer with FRĪ±-positive tumors.](https://pharmtales.com/wp-content/uploads/2023/06/ASCO-2023-MIRASOLs-ELAHERE-demonstrates-transformative-potential-in-treating-platinum-resistant-ovarian-cancer-with-FRĪ±-positive-tumors-1.jpg)
ASCO 2023: ELAHERE – A New Hope for Platinum-Resistant Ovarian Cancer Patients
SG Tylor
ABSTRACT NUMBER – LBA5507 The MIRASOL trial, presented at ASCO on June 4, demonstrated a significant improvement in the primary ...
ABSTRACT NUMBER – LBA5507 The MIRASOL trial, presented at ASCO on June 4, demonstrated a significant improvement in the primary ...